Article
Long-term follow-up of patients with phenylketonuria treated with tetrahydrobiopterin: a seven years experience.
Orphanet journal of rare diseases - 8 Feb 2015
Scala Iris, Concolino Daniela, Della Casa Roberto, Nastasi Anna, Ungaro Carla, Paladino Serena, Capaldo Brunella, Ruoppolo Margherita, Daniele Aurora, Bonapace Giuseppe, Strisciuglio Pietro, Parenti Giancarlo, Andria Generoso
Abstract excerpt
BACKGROUND: Phenylketonuria (PKU) is an autosomal recessive disorder caused by the deficiency of phenylalanine hydroxylase that catalyzes the conversion of phenylalanine to tyrosine, using tetrahydrobiopterin (BH4) as coenzyme. Besides dietary phenylalanine restriction, new therapeutic options are emerging, such as the treatment with BH4 in subgroups of PKU patients responding to a loading test with BH4. METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
